87.59
-1.09
(-1.23%)
As of 8:04:38 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 22 | 8 | 27 | 27 |
| Avg. Estimate | 7.15B | 6.65B | 28.3B | 28.43B |
| Low Estimate | 6.8B | 6.44B | 28B | 27.06B |
| High Estimate | 7.49B | 6.9B | 28.67B | 29.64B |
| Year Ago Sales | 7.12B | 6.69B | 27.12B | 28.3B |
| Sales Growth (year/est) | 0.51% | -0.54% | 4.37% | 0.47% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GIS.F | -- | -- | -- | -- |
| S&P 500 | 8.59% | 11.42% | 13.98% | 13.43% |
Upgrades & Downgrades
| Upgrade | Morgan Stanley: Equal-Weight to Overweight | 1/10/2025 |
| Reiterates | Cantor Fitzgerald: Neutral to Neutral | 12/11/2024 |
| Reiterates | RBC Capital: Sector Perform to Sector Perform | 12/11/2024 |
| Reiterates | Oppenheimer: Outperform to Outperform | 12/10/2024 |
| Maintains | UBS: Neutral to Neutral | 11/21/2024 |
| Maintains | Mizuho: Outperform to Outperform | 11/21/2024 |
Related Tickers
AMGN.MX Amgen Inc.
5,390.00
0.00%
4AB.DE AbbVie Inc.
171.30
-0.66%
JNJ.DE Johnson & Johnson
139.38
-0.21%
DSNKY Daiichi Sankyo Company, Limited
25.97
-2.44%
PFE.F Pfizer Inc.
26.15
-0.74%
ALPMY Astellas Pharma Inc.
9.47
-0.73%
SAN.PA Sanofi
94.67
-0.98%
NOV.DE Novo Nordisk A/S
83.11
-1.76%
SNY Sanofi
48.73
-1.02%
ROG.SW Roche Holding AG
264.90
-0.86%